ArticlePharmaceutics2023

HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study.

Nazende Nur Bayram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.